PerkinElmer, Inc. (NYSE:PKI) is expected to pay $0.07 on Nov 10, 2016. The indicated annual dividend is $0.28. Shareholders owning the stock before Oct 12, 2016 will be eligible to receive the payout. Based on PerkinElmer, Inc.’s current price of $55.46, the dividend is 0.13%. This dividend’s record date is Oct 14, 2016 and the announcement date is Jul 28, 2016. The stock decreased 0.43% or $0.24 during the last trading session, hitting $55.46. About 100 shares traded hands. PerkinElmer, Inc. (NYSE:PKI) has risen 16.44% since March 8, 2016 and is uptrending. It has outperformed by 7.12% the S&P500.
PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The company has a market cap of $5.99 billion. The Company’s operating divisions include Human Health, Environmental Health and Corporate. It has a 26.7 P/E ratio. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier.
Insitutional Activity: The institutional sentiment increased to 1.42 in Q2 2016. Its up 0.57, from 0.85 in 2016Q1. The ratio increased, as 23 funds sold all PerkinElmer, Inc. shares owned while 89 reduced positions. 48 funds bought stakes while 111 increased positions. They now own 97.59 million shares or 0.26% less from 97.85 million shares in 2016Q1.
Eqis Cap holds 5,298 shares or 0.02% of its portfolio. World Asset Management Inc reported 10,361 shares or 0.02% of all its holdings. Blackrock Institutional Trust Company Na, a California-based fund reported 2.89M shares. One Cap Mngmt Ltd Liability Corp holds 4,150 shares or 0.08% of its portfolio. Neuberger Berman Grp Inc Limited Liability Company last reported 0% of its portfolio in the stock. Lord Abbett Limited Liability accumulated 1.47 million shares or 0.24% of the stock. Commonwealth Equity Services Inc has 6,985 shares for 0% of their US portfolio. Capstone Investment Advsrs Limited Liability Corp holds 0.04% of its portfolio in PerkinElmer, Inc. (NYSE:PKI) for 44,152 shares. Vanguard Gp holds 0.03% of its portfolio in PerkinElmer, Inc. (NYSE:PKI) for 9.96M shares. Westwood Group holds 0.31% or 671,795 shares in its portfolio. Sector Gamma As has 5.77% invested in the company for 543,710 shares. Nationwide Fund Advsrs last reported 0.01% of its portfolio in the stock. Moreover, Employees Retirement Systems Of Texas has 0.01% invested in PerkinElmer, Inc. (NYSE:PKI) for 8,000 shares. Alliancebernstein Lp accumulated 0.01% or 191,269 shares. Natl Asset Mngmt holds 0.23% of its portfolio in PerkinElmer, Inc. (NYSE:PKI) for 22,208 shares.
Insider Transactions: Since April 15, 2016, the stock had 0 insider purchases, and 12 insider sales for $21.70 million net activity. $587,782 worth of PerkinElmer, Inc. (NYSE:PKI) was sold by FRIEL ROBERT F. Another trade for 12,586 shares valued at $686,013 was made by SATO VICKI L on Tuesday, May 10. 38,095 PerkinElmer, Inc. (NYSE:PKI) shares with value of $2.10M were sold by Goldberg Joel S. $833,420 worth of PerkinElmer, Inc. (NYSE:PKI) was sold by SICCHITANO KENTON J. The insider MICHAS ALEXIS P sold $107,122. Wilson Frank Anders had sold 46,611 shares worth $2.56M on Thursday, September 22. Another trade for 18,866 shares valued at $981,032 was made by Tereau Daniel R on Monday, September 12.
PerkinElmer, Inc. (NYSE:PKI) Ratings Coverage
Out of 11 analysts covering PerkinElmer Inc (NYSE:PKI), 3 rate it a “Buy”, 1 “Sell”, while 7 “Hold”. This means 27% are positive. PerkinElmer Inc has been the topic of 22 analyst reports since August 3, 2015 according to StockzIntelligence Inc. On Thursday, January 7 the stock rating was initiated by Deutsche Bank with “Hold”. The stock of PerkinElmer, Inc. (NYSE:PKI) earned “Neutral” rating by Wedbush on Thursday, December 3. Stifel Nicolaus maintained the shares of PKI in a report on Friday, May 6 with “Buy” rating. Maxim Group maintained the stock with “Buy” rating in Thursday, August 27 report. The stock has “Buy” rating given by Stifel Nicolaus on Friday, February 5. The stock of PerkinElmer, Inc. (NYSE:PKI) earned “Sell” rating by Goldman Sachs on Tuesday, December 8. The company was maintained on Thursday, September 22 by UBS. The stock of PerkinElmer, Inc. (NYSE:PKI) earned “Neutral” rating by BTIG Research on Friday, July 22. Bank of America downgraded the shares of PKI in a report on Tuesday, April 5 to “Neutral” rating. The stock has “Buy” rating given by Cantor Fitzgerald on Wednesday, August 26.
More recent PerkinElmer, Inc. (NYSE:PKI) news were published by: Nasdaq.com which released: “Ex-Dividend Reminder: Abbott Laboratories, PerkinElmer and Mid-America …” on October 10, 2016. Also Equitiesfocus.com published the news titled: “PerkinElmer, Inc. (NYSE:PKI) EPS Forecast At $0.92” on October 11, 2016. Businesswire.com‘s news article titled: “PerkinElmer Announces New Organizational Structure” with publication date: September 26, 2016 was also an interesting one.
PKI Company Profile
PerkinElmer, Inc., incorporated on November 13, 1947, is a well-known provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company’s operating divisions include Human Health, Environmental Health and Corporate. The Firm markets its services and products in over 150 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.